The reduction and inactivation of STAT3 lead to lipid metabolic disorders and promote triglyceride accumulation by upregulating the mRNA levels of ELOVL7, PPARG, MMP1, MMP13, and TIMP4, and downregulating the mRNA level of PTGS2. This evidence concerns the gene MMP13 and Disorder of lipid metabolism.